Labcorp Holdings Inc. LH
353.92 USD -1.67 (-0.47%)
At closeNov 3, 2026, 4:00 PM EST
353.92 0.00 0.00%
After hours · Nov 3, 4:00 PM ET
350.66 Day range 358.53
244.52 52-week range 371.00
- YTD
- +41.07%
- 1 year
- +37.26%
Analyst view
Consensus: buy
Buy
Price target (mean) 382.25 +8.0% upside
Now 353.92
- Target (low)
- 330.00
- Target (mean)
- 382.25
- Target (high)
- 420.00
Ratings (0m) 17 12 buy · 5 hold · 0 sell
- Strong buy2
- Buy10
- Hold5
- Sell0
- Strong sell0
Recommendation trend
- This month 17
- 1 month ago 17
- 2 months ago 18
- 3 months ago 18
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 4.51 | 4.34 – 4.61 | 4.07 | +10.9% | 3.76B | +6.8% | 12 |
| Next quarter | 4.54 | 4.26 – 4.79 | 4.25 | +6.7% | 3.73B | +5.5% | 10 |
| Current year | 18.48 | 18.24 – 18.62 | 16.44 | +12.4% | 14.82B | +6.2% | 17 |
| Next year | 19.59 | 17.24 – 20.65 | 18.48 | +6.0% | 15.62B | +5.4% | 18 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 29, 2026 | UBS | Maintained | Buy | Buy |
| Oct 29, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Oct 29, 2026 | Truist Securities | Maintained | Buy | Buy |
| Oct 29, 2026 | Baird | Maintained | Outperform | Outperform |
| Sep 21, 2026 | Truist Securities | Maintained | Buy | Buy |
| Sep 11, 2026 | UBS | Maintained | Buy | Buy |
| Sep 11, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Aug 4, 2026 | Piper Sandler | Maintained | Neutral | Neutral |
| Aug 3, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Jul 31, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Jul 31, 2026 | Truist Securities | Maintained | Buy | Buy |
| Jul 31, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Jul 13, 2026 | B of A Securities | Maintained | Buy | Buy |
| Jul 13, 2026 | Baird | Maintained | Outperform | Outperform |
| Apr 8, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Feb 24, 2026 | Piper Sandler | Maintained | Neutral | Neutral |
| Feb 18, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Feb 18, 2026 | Baird | Maintained | Outperform | Outperform |
| Feb 6, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Nov 7, 2025 | JP Morgan | Maintained | Overweight | Overweight |
| Oct 29, 2025 | UBS | Maintained | Buy | Buy |
| Oct 17, 2025 | UBS | Maintained | Buy | Buy |
| Oct 17, 2025 | Mizuho | Maintained | Outperform | Outperform |
| Oct 3, 2025 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Oct 2, 2025 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Jul 25, 2025 | Truist Securities | Maintained | Buy | Buy |
| Jul 25, 2025 | UBS | Maintained | Buy | Buy |
| Jul 25, 2025 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Jul 25, 2025 | Morgan Stanley | Maintained | Overweight | Overweight |
| Jul 25, 2025 | Baird | Maintained | Outperform | Outperform |
